Heranba Industries shares surged as much as 13.29% to hit an intraday high of ₹186.80 on Monday, August 24, marking the company's biggest single-day gain in over a year. The rally came after the company informed exchanges about its strategic investment decision. According to latest market data, shares traded 9.23% higher at ₹179.90, significantly outperforming the NIFTY50 index which was down 0.4%. This strong market response reflects investor confidence in the company's expansion strategy and the potential growth prospects of its subsidiary operations.
Heranba Industries Limited announced that its Board of Directors approved the investment of ₹25 crore in its subsidiary during their meeting held on August 22, 2026. The board's approval of this significant capital allocation demonstrates management's confidence in the subsidiary's growth potential and aligns with the company's broader expansion strategy. As reported in the latest stock exchange filing, the transaction involves a right issue of Mikusu India Private Limited, a wholly owned subsidiary of the company. The company has disclosed that the transaction falls under related party transaction regulations but is exempted as per Regulation 23 of SEBI listing requirements since it involves a wholly owned subsidiary.
Heranba Industries delivered mixed financial results for the quarter ended June 2026, with consolidated net profit rising 19% to ₹7.14 crore compared to ₹6 crore in the corresponding quarter of the previous year. However, the company faced revenue headwinds as sales declined 15% to ₹383 crore during the quarter, down from ₹452 crore in Q1 FY2026. According to the latest financial data, this performance reflects the company's ability to maintain profitability despite challenging market conditions and demonstrates effective cost management strategies.
Mikusu India Private Limited, the recipient of the ₹25 crore investment, is engaged in the agro chemicals business and was incorporated on April 9, 2022. The subsidiary has demonstrated strong growth momentum with turnover increasing from ₹92.91 crore in FY23-24 to ₹152.40 crore in FY24-25 and further to ₹182.68 crore in FY2025-26. As reported by the company, this investment is aimed at supporting the business operations and growth plans of Mikusu India Private Limited, positioning it for continued expansion in the agro chemicals sector. The subsidiary's consistent revenue growth trajectory supports the strategic rationale behind the current investment decision.
The company's operational efficiency showed improvement during the quarter, with operating profit margin (OPM) expanding to 12.81% from 16.90% in the previous year. PBDT (Profit Before Depreciation and Tax) increased 30% to ₹42.04 crore compared to ₹32.46 crore in Q1 FY2026, while PBT (Profit Before Tax) surged 81% to ₹20.10 crore from ₹11.12 crore in the corresponding quarter. These operational improvements contributed significantly to the overall profit growth despite the revenue decline, demonstrating the company's ability to optimize its cost structure and operational efficiency across its business segments.
